Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
Watson Pharmaceuticals
|
| gptkbp:acquisition |
gptkb:2012
gptkb:2014 gptkb:2015 Forest Laboratories |
| gptkbp:ceo |
Brent Saunders
|
| gptkbp:employees |
over 10,000
|
| gptkbp:founded |
gptkb:1984
|
| gptkbp:founder |
gptkb:Sigurdur_Olafsson
|
| gptkbp:headquarters |
gptkb:Parsippany-Troy_Hills,_New_Jersey,_USA
|
| gptkbp:healthcare |
gptkb:hospital
antibiotics antivirals antifungals antiparasitics vaccines hormonal therapies antidepressants antihypertensives diagnostic products topicals oncology drugs immunosuppressants injectables cardiovascular drugs respiratory drugs surgical products contraceptives CNS drugs gastrointestinal drugs pain management drugs neurological drugs oral solids ophthalmics transdermals dermatologicals oral liquids urological drugs |
| https://www.w3.org/2000/01/rdf-schema#label |
Actavis
|
| gptkbp:market |
global
|
| gptkbp:named_after |
gptkb:Allergan,_Inc.
|
| gptkbp:operates_in |
over-the-counter products
generic pharmaceuticals branded pharmaceuticals |
| gptkbp:products |
generic drugs
biologics specialty pharmaceuticals |
| gptkbp:revenue |
$3.5 billion (2014)
|
| gptkbp:subsidiary |
Actavis Germany Gmb H
Actavis Ireland Limited Actavis Switzerland AG Actavis UK Limited |
| gptkbp:website |
www.actavis.com
|
| gptkbp:bfsParent |
gptkb:Teva
gptkb:TEVA |
| gptkbp:bfsLayer |
4
|